Positive impactSector
Pharma mutual funds: Kotak Healthcare leads 1-year returns at over 28% — here’s how others performed
Mint 1 hr ago·9 Sept 2026, 5:54 pm
Pharma mutual funds have delivered strong returns over the past year, with some schemes outperforming the broader market. Kotak Healthcare Advantage Fund has led the pack with gains exceeding 28%, while other active funds in the sector have also posted positive numbers, though the range of performance is wide. This divergence highlights how specific stock selection and fund strategy can significantly impact results within the same sector.
For investors, this performance underscores the importance of choosing the right fund manager and strategy. While the sector has been a bright spot, the wide gap between top and bottom performers suggests that not all funds are created equal. It is crucial to review the fund's portfolio and track record before investing.
Moving forward, investors should watch for regulatory changes, drug pricing policies, and global demand trends. These factors will play a key role in determining the future performance of pharma mutual funds. Keeping an eye on these developments will help investors make informed decisions about their healthcare sector exposure.
Excerpt from Mint
Pharma and healthcare mutual funds have delivered positive returns over the last 1 year, but performance has varied sharply across schemes. While some active funds have gained more than 25%, several others have posted much lower returns. Pharma and healthcare -focused mutual funds have delivered strong returns over…Read the original at Mint
Key takeaways
- Category: Sector.
- AI reads the tone as positive (potentially bullish) for the stock.
Why it matters
A routine update. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.
